Avacta Group Plc (OTCMKTS:AVCTF – Get Free Report) traded up 3.3% during mid-day trading on Thursday . The company traded as high as $0.58 and last traded at $0.58. 1,896 shares traded hands during trading, a decline of 34% from the average session volume of 2,870 shares. The stock had previously closed at $0.56.
Avacta Group Stock Performance
The company’s fifty day moving average is $0.66 and its 200-day moving average is $0.75.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Featured Stories
- Five stocks we like better than Avacta Group
- Canadian Penny Stocks: Can They Make You Rich?
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Top 3 ETFs to Hedge Against Inflation in 2025
- The 3 Best Blue-Chip Stocks to Buy Now
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
